HOME >> BIOLOGY >> NEWS
NIAID unveils bioterrorism research agenda

tions to bioterrorism research over the years. In fiscal year 2003, the President proposes a $1.2 billion increase in bioterrorism funding for NIAID. The government's renewed focus on bioterrorism research will enable NIAID to expand ongoing projects and to establish much-needed new initiatives to prepare for potential bioterrorism attacks. New programs will involve traditional grants with academic researchers and institutions plus new models for government-industry partnerships.

According to NIAID Director Anthony S. Fauci, M.D., the proposed increase in research funding will also pay big benefits to other research. "In recent years, we have witnessed several emerging and re-emerging infectious diseases that have presented us with many of the same challenges as bioterrorism, namely identifying changing threats and preparing for them to appear at any time," he says. "In addition, people lack immunity to emerging diseases, and effective treatments are not always known. The influx of resources and renewed energy into infectious diseases research will no doubt help us enormously in tackling naturally occurring illnesses such as drug-resistant tuberculosis and influenza." Dr. Fauci also describes how increased basic research in immunology, including studies of the body's broadly protective innate immune system, should lead to additional advances in many non-infectious diseases such as cancer and autoimmune diseases.

The Research Agenda describes two separate but necessary arms of biomedical research. Basic research will continue to provide the framework for scientific and medical advances, and applied research will move laboratory developments into products that can be used to protect the public from disease. The agenda divides research on each Category A microbe into six key elements:

  • Microbial biology. Increased basic research will help scientists acquire comprehensive information on the biology and disease-causing
    '"/>


Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
14-Mar-2002


Page: 1 2 3 4

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID takes next genome step
3. NIAID awards grant to rapidly sequence the malaria mosquito genome
4. NIAID launches major step in trial of experimental shingles vaccine
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. Pacific Northwest team unveils largest virus proteome to date
9. Pacific Northwest National Lab unveils most complete human blood-plasma proteome map to date
10. Department of Energys Office of Science unveils 20-year vision for the future of basic research
11. Ancient DNA analysis unveils mystery of historys most horribly deformed man -- The Elephant Man

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/5/2019)... WA (PRWEB) , ... November 05, 2019 , ... ... & Amato Dentistry, providing state-of-the-art cosmetic and restorative dentistry to Seattle, WA, including ... her Doctor of Dental Surgery degree from the University of Washington, Dr. Kopp ...
(Date:11/2/2019)... , ... November 01, 2019 , ... Stay on top ... and medical device industries. Access to all webinars is free, so be sure to ... your field! , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL ...
(Date:10/30/2019)... , ... October 30, 2019 , ... ... the Farm Credit Knowledge Center in which participants will learn about precision agriculture ... practice relating to these technologies. , Participants will have the opportunity to ...
Breaking Biology News(10 mins):
(Date:11/6/2019)... ... November 06, 2019 , ... Diversified Technologies, Inc. has ... and vegetables per hour to improve processing. , The DTI Industrial PEF Unit can ... hour to increase juice yields by up to 50% and achieve up to an ...
(Date:11/2/2019)... ... October 31, 2019 , ... A clinical trial usually involves ... study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. ... the latest data, potentially leading to patient risk. , By having a single ...
(Date:10/29/2019)... ... October 28, 2019 , ... CaroGen Corporation , a biotechnology ... , Professor Jack R Wands, MD, of Brown University , ... Professor Gil Mor, MD, PhD, of Wayne State University, formerly a professor at ...
(Date:10/22/2019)... , ... October 22, 2019 , ... Catalent, a global ... Services and Drug Product Technologies Integration, will participate in a panel session titled “Cell ... to be held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019. , The ...
Breaking Biology Technology:
Cached News: